Overview A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndromes. Phase: Phase 2 Details Lead Sponsor: Kissei Pharmaceutical Co., Ltd.